|
FY2025
12 months to Jun 30, 2025
|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
FY2021
12 months to Jun 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Stock-based compensation expense | |||||
| Amortization of loan commitment fee | |||||
| Changes in operating assets and liabilities: | |||||
| Grant receivable | |||||
| Prepaid expenses | |||||
| Accounts payable | |||||
| Accrued expenses | |||||
| Net cash used in operating activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from issuance of common stock | |||||
| Proceeds from issuance of common stock upon exercise of options | |||||
| Payment of financing/offering costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of period | |||||
| Cash and cash equivalents, end of the period | |||||
| Noncash investing and financing activities: | |||||
| Financing commitment fee funded through issuance of common stock | |||||
Loading...